ASND vs. ATR: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at ASND and ATR, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
ASND trades as an American Depositary Receipt (ADR), offering U.S. investors a convenient way to access its foreign-listed shares. In contrast, ATR is a standard domestic listing.
| Symbol | ASND | ATR |
|---|---|---|
| Company Name | Ascendis Pharma A/S | AptarGroup, Inc. |
| Country | Denmark | United States |
| GICS Sector | Health Care | Materials |
| GICS Industry | Biotechnology | Containers & Packaging |
| Market Capitalization | 12.36 billion USD | 8.78 billion USD |
| Exchange | NasdaqGS | NYSE |
| Listing Date | January 28, 2015 | April 23, 1993 |
| Security Type | ADR | Common Stock |
Historical Performance
This chart compares the performance of ASND and ATR by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | ASND | ATR |
|---|---|---|
| 5-Day Price Return | 6.50% | 0.72% |
| 13-Week Price Return | 17.15% | -17.28% |
| 26-Week Price Return | 30.92% | -10.22% |
| 52-Week Price Return | 39.48% | -16.08% |
| Month-to-Date Return | 2.64% | -0.33% |
| Year-to-Date Return | 48.22% | -15.20% |
| 10-Day Avg. Volume | 0.45M | 0.37M |
| 3-Month Avg. Volume | 0.46M | 0.42M |
| 3-Month Volatility | 32.21% | 24.70% |
| Beta | 0.44 | 0.53 |
Profitability
Return on Equity (TTM)
ASND
-257.14%
Biotechnology Industry
- Max
- 97.92%
- Q3
- 11.99%
- Median
- -19.30%
- Q1
- -51.29%
- Min
- -132.03%
ASND has a negative Return on Equity of -257.14%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.
ATR
15.30%
Containers & Packaging Industry
- Max
- 36.99%
- Q3
- 19.86%
- Median
- 10.47%
- Q1
- 6.76%
- Min
- -0.20%
ATR’s Return on Equity of 15.30% is on par with the norm for the Containers & Packaging industry, indicating its profitability relative to shareholder equity is typical for the sector.
Net Profit Margin (TTM)
ASND
-55.25%
Biotechnology Industry
- Max
- 73.34%
- Q3
- 18.98%
- Median
- -12.96%
- Q1
- -105.72%
- Min
- -259.82%
ASND has a negative Net Profit Margin of -55.25%, indicating the company is operating at a net loss as its expenses exceeded its revenues.
ATR
10.86%
Containers & Packaging Industry
- Max
- 10.84%
- Q3
- 8.25%
- Median
- 4.91%
- Q1
- 3.65%
- Min
- -0.12%
ATR’s Net Profit Margin of 10.86% is exceptionally high, placing it well beyond the typical range for the Containers & Packaging industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.
Operating Profit Margin (TTM)
ASND
-51.66%
Biotechnology Industry
- Max
- 78.85%
- Q3
- 21.90%
- Median
- -13.30%
- Q1
- -109.94%
- Min
- -278.10%
ASND has a negative Operating Profit Margin of -51.66%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.
ATR
14.26%
Containers & Packaging Industry
- Max
- 22.03%
- Q3
- 13.09%
- Median
- 8.06%
- Q1
- 6.46%
- Min
- -0.07%
An Operating Profit Margin of 14.26% places ATR in the upper quartile for the Containers & Packaging industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
Profitability at a Glance
| Symbol | ASND | ATR |
|---|---|---|
| Return on Equity (TTM) | -257.14% | 15.30% |
| Return on Assets (TTM) | -24.52% | 8.50% |
| Net Profit Margin (TTM) | -55.25% | 10.86% |
| Operating Profit Margin (TTM) | -51.66% | 14.26% |
| Gross Profit Margin (TTM) | 84.88% | 38.32% |
Financial Strength
Current Ratio (MRQ)
ASND
1.02
Biotechnology Industry
- Max
- 16.97
- Q3
- 8.39
- Median
- 4.11
- Q1
- 2.64
- Min
- 0.74
ASND’s Current Ratio of 1.02 falls into the lower quartile for the Biotechnology industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
ATR
1.21
Containers & Packaging Industry
- Max
- 1.96
- Q3
- 1.45
- Median
- 1.33
- Q1
- 1.09
- Min
- 0.87
ATR’s Current Ratio of 1.21 aligns with the median group of the Containers & Packaging industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
ASND
7.81
Biotechnology Industry
- Max
- 1.92
- Q3
- 0.79
- Median
- 0.12
- Q1
- 0.00
- Min
- 0.00
With a Debt-to-Equity Ratio of 7.81, ASND operates with exceptionally high leverage compared to the Biotechnology industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.
ATR
0.40
Containers & Packaging Industry
- Max
- 4.15
- Q3
- 2.03
- Median
- 1.20
- Q1
- 0.53
- Min
- 0.23
Falling into the lower quartile for the Containers & Packaging industry, ATR’s Debt-to-Equity Ratio of 0.40 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.
Interest Coverage Ratio (TTM)
ASND
-4.54
Biotechnology Industry
- Max
- 72.37
- Q3
- 1.03
- Median
- -9.59
- Q1
- -65.05
- Min
- -163.11
ASND has a negative Interest Coverage Ratio of -4.54. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.
ATR
16.67
Containers & Packaging Industry
- Max
- 13.16
- Q3
- 8.10
- Median
- 3.38
- Q1
- 2.83
- Min
- 1.06
With an Interest Coverage Ratio of 16.67, ATR demonstrates a superior capacity to service its debt, placing it well above the typical range for the Containers & Packaging industry. This stems from either robust earnings or a conservative debt load.
Financial Strength at a Glance
| Symbol | ASND | ATR |
|---|---|---|
| Current Ratio (MRQ) | 1.02 | 1.21 |
| Quick Ratio (MRQ) | 0.66 | 0.83 |
| Debt-to-Equity Ratio (MRQ) | 7.81 | 0.40 |
| Interest Coverage Ratio (TTM) | -4.54 | 16.67 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
ASND
0.00%
Biotechnology Industry
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
ASND currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
ATR
1.37%
Containers & Packaging Industry
- Max
- 7.14%
- Q3
- 4.65%
- Median
- 3.69%
- Q1
- 2.00%
- Min
- 0.00%
ATR’s Dividend Yield of 1.37% is in the lower quartile for the Containers & Packaging industry. This suggests the company’s strategy likely favors retaining earnings for growth over providing a high dividend income.
Dividend Payout Ratio (TTM)
ASND
0.00%
Biotechnology Industry
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
ASND has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
ATR
30.61%
Containers & Packaging Industry
- Max
- 222.75%
- Q3
- 132.16%
- Median
- 65.79%
- Q1
- 28.53%
- Min
- 0.00%
ATR’s Dividend Payout Ratio of 30.61% is within the typical range for the Containers & Packaging industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
Dividend at a Glance
| Symbol | ASND | ATR |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 1.37% |
| Dividend Payout Ratio (TTM) | 0.00% | 30.61% |
Valuation
Price-to-Earnings Ratio (TTM)
ASND
--
Biotechnology Industry
- Max
- 40.44
- Q3
- 39.37
- Median
- 22.12
- Q1
- 15.76
- Min
- 3.48
P/E Ratio data for ASND is currently unavailable.
ATR
22.28
Containers & Packaging Industry
- Max
- 24.22
- Q3
- 20.28
- Median
- 17.07
- Q1
- 15.06
- Min
- 7.79
A P/E Ratio of 22.28 places ATR in the upper quartile for the Containers & Packaging industry. This high valuation relative to peers suggests the market holds elevated expectations for the company’s future growth.
Price-to-Sales Ratio (TTM)
ASND
21.13
Biotechnology Industry
- Max
- 92.67
- Q3
- 41.36
- Median
- 8.45
- Q1
- 4.46
- Min
- 0.97
ASND’s P/S Ratio of 21.13 aligns with the market consensus for the Biotechnology industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
ATR
2.42
Containers & Packaging Industry
- Max
- 1.99
- Q3
- 1.17
- Median
- 0.94
- Q1
- 0.55
- Min
- 0.31
With a P/S Ratio of 2.42, ATR trades at a valuation that eclipses even the highest in the Containers & Packaging industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.
Price-to-Book Ratio (MRQ)
ASND
67.28
Biotechnology Industry
- Max
- 22.72
- Q3
- 10.68
- Median
- 4.55
- Q1
- 2.44
- Min
- 0.59
At 67.28, ASND’s P/B Ratio is at an extreme premium to the Biotechnology industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.
ATR
3.83
Containers & Packaging Industry
- Max
- 4.79
- Q3
- 3.32
- Median
- 2.14
- Q1
- 1.60
- Min
- 0.89
ATR’s P/B Ratio of 3.83 is in the upper tier for the Containers & Packaging industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.
Valuation at a Glance
| Symbol | ASND | ATR |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | -- | 22.28 |
| Price-to-Sales Ratio (TTM) | 21.13 | 2.42 |
| Price-to-Book Ratio (MRQ) | 67.28 | 3.83 |
| Price-to-Free Cash Flow Ratio (TTM) | -- | 25.54 |